Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Lilly Ventures

Profile, fund size and leaders

Parent Eli Lilly and CompanyHQ Indianapolis, United StatesFounded 2001

Lilly Ventures is the corporate venture arm of Eli Lilly and Company, a pharmaceutical and biotech company. It was founded in 2001 and is based in Indianapolis, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences, healthcare and digital health.

AUM or capital under managementS2
USD 2bn+

Every figure links to its source

Snapshot

Investment stage: Seed to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series A
SectorsBiotech and life sciences, Healthcare and digital health
GeographyGlobal
OfficesIndianapolis, United States

Sources: S1 Global Venturing: Powerlist 2026, Brad Robling; S2 Global Venturing: Emerging Leaders 2026, Laura Daily.

Graphic 1 of 2

Investment stage: Seed to Series A

Sources: S1 Global Venturing: Powerlist 2026, Brad Robling; S2 Global Venturing: Emerging Leaders 2026, Laura Daily.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 2bn+AUM or capital under managementStated by the firm or its parentS2

Sources: S2 Global Venturing: Emerging Leaders 2026, Laura Daily.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S2 Global Venturing: Emerging Leaders 2026, Laura Daily.

Download:Report a correction

Where it invests and who leads it

Geography

Investment regionsS1S2

LeadersS6S2

Lilly Ventures on LinkedIn

Key facts

FactValueStatusSource
Parent companyEli Lilly and CompanySingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded2001Single sourceS7
HeadquartersIndianapolis, United StatesSingle sourceS4
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS2
Headline sizeUSD 2bn+ (AUM or capital under management)Single sourceS2
StagesSeed, Series ASingle sourceS1

Fund vehicles

VehicleSizeYearSource
Social Impact Venture Capital Portfolio (impact, fund of funds)USD 300MS1
Biotech Ecosystem Venture Fund (managed by a16z Bio + Health, Lilly partner)USD 500M2025S3
Tech-focused fund started 2023 (name not given)Not published2023S1

For founders

ItemWhat the firm saysSource
StagesSeed, Series AS1
Beyond capitalCatalyze360 platform: lab space , R&D capabilities and scientific engagement alongside capitalS1

Recent rounds

DateCompanyRoundAmountSource
Remedium BioSeries AUSD 10MS1

History

  1. Brad Robling begins heading Lilly Ventures (GCV).S1
  2. Tech-focused fund started (GCV).S1
  3. Lilly and a16z Bio + Health launch the Biotech Ecosystem Venture Fund, up to $500 million.S3

Official pages

Read the firm's own pages for current information.

  • Website www.lilly.com/science/partners/catalyze-360
  • Portfolio raisehunt.com/funds/lilly-ventures

Sources

  1. S1Global Venturing: Powerlist 2026, Brad RoblingPress
  2. S2Global Venturing: Emerging Leaders 2026, Laura DailyPress
  3. S3HLTH: Andreessen Horowitz and Eli Lilly launch $500M Biotech Ecosystem FundPress
  4. S4SEC EDGAR: Lilly Ventures Fund I LLC (Form D filer, Indianapolis)Filing
  5. S5Lilly Catalyze360 page (names Lilly Ventures as global investment arm)Firm
  6. S6Lilly partnering team page: Lilly Ventures Global Head and Venture Science headsFirm
  7. S7Indianapolis Business Journal: Lilly reorganizes venture capital unit (formed in 2001)Press
  8. S8RaiseHunt: Lilly Ventures portfolio list (third-party; Lilly publishes no portfolio list)Third-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Lilly Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.